| Michele Migliuolo, Ph.D. – Dr. Migliuolo is President and CEO of NeuroInterventional Therapeutics, Inc., a Pittsburgh-based company which designs and manufacturers advanced catheter systems used to find, trap, and extract blood clots in a wide range of cerebral vessels, and where necessary deliver therapeutics to the diseased site after clot removal. Michele received a Doctorate in Physics from the University of Rome (Italy). He also holds M.A. and Ph.D. degrees in Physics from the University of Rochester. He has twenty years experience as an executive in manufacturing and sales of scientific capital equipment and analytical instruments. He has launched foreign products in the United States including mass spectrometers, and imaging chemical microscopes and has launched American products abroad, including thin film deposition systems and surface analysis systems. He has grown small business units from infancy to multimillion-dollar product lines. His expertise is with worldwide customers ranging from academic-government research laboratories, to medical device, semiconductor, superconductor, data storage, electro-optic, microscopy, and analytical chemistry industries. Previously, he was Vice President of Technology at the Kurt J. Lesker Company, Vice President of Sales and Marketing at E.A. Fischione Instruments Inc., and President of XACTIX, a manufacturer of process equipment for the MEMS industry. Most recently, his experience includes positions at The Pittsburgh Life Sciences Greenhouse, Seagate Technology (Sr. Director of Research), Vice President at Powercast, and Founder and CEO of Verimetra, Inc., a startup manufacturer of Microelectromechanical Systems (MEMS) biomedical devices and sensors. Dr. Migliuolo is fluent in multiple languages, and is a member of the APS, and the IEEE, and has published over eighty papers, including patents, refereed publications, contributed proceedings and invited presentations. |